BiotechTube
Cellec Biotek

Cellec Biotek

Zürich, Switzerland· Est.
cellecbiotek.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Cellec Biotek is a private, revenue-generating tools and services company focused on the niche but growing market of 3D cell culture systems. Its proprietary U-CUP bioreactor platform allows researchers to cultivate complex 3D tissues under controlled perfusion, positioning it as an enabler for advanced drug discovery and tissue engineering. While not developing its own therapeutics, the company serves as a critical supplier to academic, biotech, and pharmaceutical partners, leveraging its origins as a spin-off from the University Hospital Basel. Its business model is based on selling bioreactor hardware, disposable kits, and associated consumables.

Cell TherapyBiologics

Technology Platform

U-CUP perfusion bioreactor system for 3D cell and tissue culture under controlled medium flow.

Opportunities

The growing demand for physiologically relevant 3D tissue models in drug discovery and toxicity testing, driven by regulatory shifts away from animal testing, presents a major tailwind.
Expansion into adjacent markets like cellular agriculture for cultured meat production could provide additional growth avenues.

Risk Factors

Intense competition from large, well-capitalized life science tools corporations and the risk of technological disruption if simpler or cheaper 3D culture methods gain favor.
As a small, niche player, the company is also vulnerable to fluctuations in academic and pharmaceutical R&D budgets.

Competitive Landscape

Cellec Biotek competes in the specialized bioreactor segment against companies like Synthecon (3D bioreactors) and smaller innovators, as well as the broader 3D culture portfolios of giants like Sartorius (with its ambr and Incucyte systems) and Thermo Fisher Scientific. Its differentiation lies in the specific focus on user-friendly, perfusion-based systems for research-scale 3D tissue culture.

More companies in Switzerland →